DK150534C - Fremgangsmaade til fremstilling af et farmaceutisk praeparat med forsinket afgivelse af en aktiv bestanddel - Google Patents

Fremgangsmaade til fremstilling af et farmaceutisk praeparat med forsinket afgivelse af en aktiv bestanddel

Info

Publication number
DK150534C
DK150534C DK523277A DK523277A DK150534C DK 150534 C DK150534 C DK 150534C DK 523277 A DK523277 A DK 523277A DK 523277 A DK523277 A DK 523277A DK 150534 C DK150534 C DK 150534C
Authority
DK
Denmark
Prior art keywords
preparing
procedure
active ingredient
pharmaceutical preparation
delayed delivery
Prior art date
Application number
DK523277A
Other languages
English (en)
Other versions
DK523277A (da
DK150534B (da
Inventor
Yegnaswami Raghunathan
Original Assignee
Pennwalt Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pennwalt Corp filed Critical Pennwalt Corp
Publication of DK523277A publication Critical patent/DK523277A/da
Publication of DK150534B publication Critical patent/DK150534B/da
Application granted granted Critical
Publication of DK150534C publication Critical patent/DK150534C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
DK523277A 1976-11-26 1977-11-25 Fremgangsmaade til fremstilling af et farmaceutisk praeparat med forsinket afgivelse af en aktiv bestanddel DK150534C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US74532576A 1976-11-26 1976-11-26
US74532576 1976-11-26
US80010577A 1977-05-24 1977-05-24
US80010577 1977-05-24

Publications (3)

Publication Number Publication Date
DK523277A DK523277A (da) 1978-05-27
DK150534B DK150534B (da) 1987-03-23
DK150534C true DK150534C (da) 1987-10-12

Family

ID=27114439

Family Applications (1)

Application Number Title Priority Date Filing Date
DK523277A DK150534C (da) 1976-11-26 1977-11-25 Fremgangsmaade til fremstilling af et farmaceutisk praeparat med forsinket afgivelse af en aktiv bestanddel

Country Status (21)

Country Link
JP (1) JPS609697B2 (da)
AR (1) AR218047A1 (da)
AT (1) AT359197B (da)
AU (1) AU511080B2 (da)
BE (1) BE861141A (da)
CA (1) CA1086226A (da)
CH (1) CH639560A5 (da)
DE (1) DE2752728C2 (da)
DK (1) DK150534C (da)
FI (1) FI65910C (da)
FR (1) FR2373288A1 (da)
GB (1) GB1544761A (da)
GR (1) GR61724B (da)
IE (1) IE45998B1 (da)
IL (1) IL53462A (da)
LU (1) LU78584A1 (da)
NL (1) NL182283C (da)
NO (1) NO147626C (da)
NZ (1) NZ185772A (da)
PT (1) PT67323B (da)
SE (1) SE426781B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2929456A1 (de) 1979-07-20 1981-02-05 Lentia Gmbh Zusammensetzung mit verlaengerter broncholytischer und tokolytischer wirksamkeit, ein verfahren zu deren herstellung und broncholytisch und tokolytisch wirkendes mittel
CA1236023A (en) * 1984-07-18 1988-05-03 Yegnaswami Raghunathan Controlled release pharmaceutical preparations
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
US5188825A (en) * 1989-12-28 1993-02-23 Iles Martin C Freeze-dried dosage forms and methods for preparing the same
EP0542926B1 (en) * 1990-08-07 1995-02-15 Pfizer Inc. Use of interfacially-polymerized membranes in delivery devices
US5436011A (en) * 1993-04-16 1995-07-25 Bristol-Myers Squibb Company Solid pharmaceutical dosage form and a method for reducing abrasion
US20130230587A1 (en) * 2010-11-10 2013-09-05 Rubicon Research Private Limited Sustained release compositions
FR3059903B1 (fr) * 2016-12-08 2019-03-22 Salsarulo Pharma Medicament oral comprenant un laxatif osmotique incorpore dans une matrice a base de matieres grasses vegetales
WO2019074829A1 (en) 2017-10-09 2019-04-18 Rhodes Pharmaceuticals L.P. RESINATE-BASED PHARMACEUTICAL COMPOSITIONS, AND METHODS OF MAKING AND USING THEM

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE550150A (da) * 1955-08-08
GB843118A (en) * 1957-02-13 1960-08-04 Ici Ltd Pharmaceutical compositions containing piperidine derivatives
US3158538A (en) * 1961-02-23 1964-11-24 White Lab Inc Antidiarrheal compositions and method of using
GB982150A (en) * 1961-09-29 1965-02-03 Glaxo Group Ltd Therapeutic resin complexes
US3594470A (en) * 1968-02-19 1971-07-20 Abbott Lab Chewable tablets including coated particles of pseudoephedrine-weak cation exchange resin
GB1218102A (en) * 1968-03-15 1971-01-06 Philips Nv Improvements in medicaments comprising drug/ion-exchange resin compounds
CA927282A (en) * 1968-09-03 1973-05-29 S. Banker Gilbert Entrapment compositions and processes
CA935092A (en) * 1968-09-03 1973-10-09 S. Banker Gilbert Molecular drug entrapment process and compositions
DE2343218C2 (de) * 1973-08-28 1986-08-07 Hoechst Ag, 6230 Frankfurt Furosemid enthaltende Pellets

Also Published As

Publication number Publication date
FR2373288B1 (da) 1980-06-13
JPS609697B2 (ja) 1985-03-12
NO147626C (no) 1983-05-25
ATA848077A (de) 1980-03-15
GR61724B (en) 1978-12-29
NL182283C (nl) 1988-02-16
IL53462A0 (en) 1978-01-31
CA1086226A (en) 1980-09-23
DE2752728A1 (de) 1978-06-01
NZ185772A (en) 1978-12-18
AR218047A1 (es) 1980-05-15
DK523277A (da) 1978-05-27
IE45998L (en) 1978-05-26
JPS5369822A (en) 1978-06-21
SE426781B (sv) 1983-02-14
FI773568A (fi) 1978-05-27
SE7713370L (sv) 1978-05-27
DE2752728C2 (de) 1985-08-01
PT67323B (en) 1979-04-24
AU3098677A (en) 1979-05-31
IL53462A (en) 1980-12-31
AT359197B (de) 1980-10-27
BE861141A (fr) 1978-03-16
GB1544761A (en) 1979-04-25
FI65910C (fi) 1984-08-10
FI65910B (fi) 1984-04-30
NO147626B (no) 1983-02-07
PT67323A (en) 1977-12-01
CH639560A5 (en) 1983-11-30
NL182283B (nl) 1987-09-16
LU78584A1 (da) 1978-04-20
IE45998B1 (en) 1983-01-26
NL7712996A (nl) 1978-05-30
NO774051L (no) 1978-05-29
AU511080B2 (en) 1980-07-24
FR2373288A1 (fr) 1978-07-07
DK150534B (da) 1987-03-23

Similar Documents

Publication Publication Date Title
DK513476A (da) Fremgangsmade til fremstilling af preparater med kontrolleret afgivelse af en virksom bestanddel
DK153440C (da) Fremgangsmaade til fremstilling af et nasalt farmaceutisk ergotpeptidalkaloid-praeparat
DK148344C (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat med forlaenget afgivelse af aktivt stof
DK153773C (da) Fremgangsmaade til fremstillling af et farmaceutisk praeparat til forlaenget frigoerelse af et laegemiddel
DK371277A (da) Fremgangsmaade til fremstilling af farmaceutiske doseringsformer med vedvarende virkning
RO75336A (ro) Procedeu pentru prepararea unei forme farmaceutice destinate administrarii transdermale a clonidinei
DK562276A (da) Fremgangsmaade til fremstilling af en farmaceutisk administrationsform
NO149035C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive acylanilid-derivater
DK150812C (da) Fremgangsmaade til fremstilling af et kapsellegeme, isaer en laegemiddeldoseringskapsel
DK160739C (da) Fremgangsmaade til fremstilling af et stabilt prostaglandinindeholdende praeparat til laegemiddelanvendelse
DK143407C (da) Fremgangsmaade til fremstilling af et stift polyurinstofskum
DK528879A (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende isosorbiddinitrat
DK158836C (da) Analogifremgangsmaade til fremstilling af terapeutisk aktive anthraquinonderivater
DK150534C (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat med forsinket afgivelse af en aktiv bestanddel
DK203879A (da) Fremgangsmaade til fremstilling af en farmaceutisk doseringskomponent
SE7604317L (sv) Fast farmaceutisk doseringsform med fordrojd frigoring och sett att framstella desamma
DK98076A (da) Fremgangsmade til fremstilling af et farmaceutisk preparat
NO772575L (no) Fremgangsm}te for fremstilling av farmas¦ytisk aktive preparater
DK352578A (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat
DK154607C (da) Fremgangsmaade til fremstilling af en laegemiddelform til oral administration af ergotalkaloider
DK313281A (da) Anordning til indgift af medicinsk aktive substanser
DK143173C (da) Fremgangsmaade til fremstilling af et urinstof-urinstofphosphatholdigt droevtyggerfoder
NO784325L (no) Analogifremgangsmaate for fremstilling av farmasoeytisk aktive tetracyklononanderivater
DK529278A (da) Fremgangsmaade til fremstilling af farmaceutisk virksomme thiolestere
DK159136C (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat til rectal indgivning

Legal Events

Date Code Title Description
PUP Patent expired